1. Home
  2. GNLX vs CODA Comparison

GNLX vs CODA Comparison

Compare GNLX & CODA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • GNLX
  • CODA
  • Stock Information
  • Founded
  • GNLX 2001
  • CODA 1994
  • Country
  • GNLX United States
  • CODA United States
  • Employees
  • GNLX N/A
  • CODA N/A
  • Industry
  • GNLX Biotechnology: Pharmaceutical Preparations
  • CODA Industrial Machinery/Components
  • Sector
  • GNLX Health Care
  • CODA Industrials
  • Exchange
  • GNLX Nasdaq
  • CODA Nasdaq
  • Market Cap
  • GNLX 112.5M
  • CODA 88.7M
  • IPO Year
  • GNLX 2023
  • CODA N/A
  • Fundamental
  • Price
  • GNLX $3.44
  • CODA $8.10
  • Analyst Decision
  • GNLX Strong Buy
  • CODA Strong Buy
  • Analyst Count
  • GNLX 4
  • CODA 1
  • Target Price
  • GNLX $17.75
  • CODA $11.00
  • AVG Volume (30 Days)
  • GNLX 152.2K
  • CODA 59.6K
  • Earning Date
  • GNLX 08-13-2025
  • CODA 06-16-2025
  • Dividend Yield
  • GNLX N/A
  • CODA N/A
  • EPS Growth
  • GNLX N/A
  • CODA 21.86
  • EPS
  • GNLX N/A
  • CODA 0.30
  • Revenue
  • GNLX N/A
  • CODA $22,758,966.00
  • Revenue This Year
  • GNLX N/A
  • CODA $11.64
  • Revenue Next Year
  • GNLX N/A
  • CODA $14.53
  • P/E Ratio
  • GNLX N/A
  • CODA $26.83
  • Revenue Growth
  • GNLX N/A
  • CODA 24.78
  • 52 Week Low
  • GNLX $1.60
  • CODA $5.76
  • 52 Week High
  • GNLX $5.89
  • CODA $9.89
  • Technical
  • Relative Strength Index (RSI)
  • GNLX 65.71
  • CODA 57.37
  • Support Level
  • GNLX $2.80
  • CODA $7.81
  • Resistance Level
  • GNLX $3.61
  • CODA $8.50
  • Average True Range (ATR)
  • GNLX 0.22
  • CODA 0.41
  • MACD
  • GNLX 0.05
  • CODA -0.01
  • Stochastic Oscillator
  • GNLX 80.23
  • CODA 63.45

About GNLX Genelux Corporation

Genelux Corp is a clinical-stage biopharmaceutical company. The company focuses on developing next-generation oncolytic viral immunotherapies for patients suffering from aggressive or difficult-to-treat solid tumor types. Its pipeline products include Olvi-Vec (olvimulogene nanivacirepvec), Lung, and Pancreatic Cancer.

About CODA Coda Octopus Group Inc. Common stock

Coda Octopus Group Inc develops underwater technologies and equipment for imaging, mapping defense, and survey applications. The company's operations are organized into two reportable segments: the Products Segment (Marine Technology Business serving the subsea market and PAL, which sells other products (acoustic hydrophones and acoustic materials to a different market); and the Services Segment (Marine Engineering Business). Its geographical segments are the Americas, Europe, Australia/Asia, and the Middle East/Africa. The majority of revenue is derived from the Products segment.

Share on Social Networks: